AG
XERS icon

Algert Global’s Xeris Biopharma Holdings XERS Stock Holding History

Algert Global’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8M Buy
1,742,942
+585,984
+51% +$3.74M 0.16% 178
2026
Q1 		$6.71M Buy
1,156,958
+438,114
+61% +$2.9M 0.1% 347
2025
Q4 		$5.64M Buy
718,844
+560,884
+355% +$4.41M 0.09% 388
2025
Q3 		$1.29M Buy
+157,960
New +$1.05M 0.02% 795
2021
Q3 		– Sell
-19,840
Closed -$81K – 1084
2021
Q2 		$81K Buy
+19,840
New +$75.7K 0.03% 399
2020
Q2 		– Sell
-12,020
Closed -$23K – 513
2020
Q1 		$23K Buy
+12,020
New +$51.7K 0.01% 398

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Algert Global's XERS Position: Q2 2026 in Review

Algert Global increased its Xeris Biopharma Holdings (XERS) stake by 51% in Q2 2026, buying an estimated $3.74M and bringing the position to 1,742,942 shares worth $13.8M. The position accounts for 0.16% of the portfolio, ranked #178.

Algert Global first reported a position in XERS in Q1 2020 and has held it in 6 quarters since. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Algert Global held 1,742,942 shares of Xeris Biopharma Holdings worth $13.8M as of Q2 2026.
  • Algert Global bought 585,984 Xeris Biopharma Holdings shares in Q2 2026, an estimated $3.74M.
  • Xeris Biopharma Holdings made up 0.16% of Algert Global's portfolio in Q2 2026, its #178 holding.
  • Algert Global first reported a position in Xeris Biopharma Holdings in Q1 2020 and has held it in 6 quarters since.
  • 241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.